| 000 | 01793 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516160738.0 | ||
| 264 | 0 | _c20131224 | |
| 008 | 201312s 0 0 eng d | ||
| 022 | _a1096-8652 | ||
| 024 | 7 |
_a10.1002/ajh.23540 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZinzani, Pier Luigi | |
| 245 | 0 | 0 |
_aFludarabine-mitoxantrone-rituximab regimen in untreated intermediate/high-risk follicular non-Hodgkin's lymphoma: experience on 142 patients. _h[electronic resource] |
| 260 |
_bAmerican journal of hematology _cNov 2013 |
||
| 300 |
_aE273-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Murine-Derived _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphoma, Follicular _xdiagnosis |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMitoxantrone _xadministration & dosage |
| 650 | 0 | 4 | _aNeoplasm Grading |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRituximab |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 |
_aVidarabine _xadministration & dosage |
| 700 | 1 | _aPellegrini, Cinzia | |
| 700 | 1 | _aBroccoli, Alessandro | |
| 700 | 1 | _aCasadei, Beatrice | |
| 700 | 1 | _aArgnani, Lisa | |
| 700 | 1 | _aPileri, Stefano | |
| 773 | 0 |
_tAmerican journal of hematology _gvol. 88 _gno. 11 _gp. E273-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/ajh.23540 _zAvailable from publisher's website |
| 999 |
_c22907582 _d22907582 |
||